文献速递临床免疫

多参数IgA检测用于乳糜泻诊断的性能评估

Evaluating the performance of a multiparametric IgA assay for celiac disease diagnosis.
PubMed 文献 · Clin Chem Lab Med · 2025-08-20

本研究回顾性纳入180名参与者,评估基于膜载体的多参数酶免疫检测(AESKUBLOTS®)同时检测8种乳糜泻相关抗原IgA抗体的诊断性能。结果显示抗tTG新抗原IgA的AUC最高(0.93),复合评分≥4个阳性标志物AUC达0.99,≥6个阳性标志物特异性与PPV均为100%、敏感性76.7%。

要点

  • 抗tTG新抗原IgA抗体诊断准确性最高,AUC为0.93。
  • 复合评分≥6个阳性标志物时特异性与PPV均达100%,敏感性76.7%。
  • 抗mTG IgA在所有乳糜泻患者中升高,不受饮食影响。

核心结论

  • 该多参数IgA检测为乳糜泻提供了一种敏感、特异且非侵入性的诊断工具。
  • 抗tTG新抗原IgA和抗tTG IgA表现出高诊断准确性。
  • 抗mTG IgA可能在监测或识别持续黏膜免疫活动方面有潜在用途。

研究设计与样本

  • 回顾性单中心研究,纳入180名参与者:80例乳糜泻患者(30例未治疗、50例无麸质饮食)、50例非乳糜泻小麦敏感者、50例健康对照。
  • 使用AESKUBLOTS®膜载体酶免疫检测分析血清样本,通过ROC曲线分析和5折交叉验证评估诊断准确性。

主要发现

  • 未治疗乳糜泻患者中检测性能尤为突出,抗tTG新抗原IgA的AUC=0.93,抗tTG IgA的AUC=0.92。
  • 复合评分≥4个阳性标志物时AUC=0.99;≥6个阳性标志物时特异性100%、PPV 100%、敏感性76.7%。
  • 抗mTG IgA水平在所有乳糜泻患者中升高,无论是否进行无麸质饮食。

关键数值与推荐

  • 抗tTG新抗原IgA:AUC=0.93;抗tTG IgA:AUC=0.92。
  • 复合评分≥4个阳性标志物:AUC=0.99。
  • 复合评分≥6个阳性标志物:特异性100%、PPV 100%、敏感性76.7%。

临床怎么用

  • 该多参数IgA检测可作为乳糜泻的非侵入性诊断辅助工具,尤其适用于未治疗患者。
  • 复合评分≥6个阳性标志物时特异性极高,有助于确诊;抗mTG IgA或可用于监测黏膜免疫活动。

局限性

  • 需更大规模的前瞻性研究确认临床效用并扩展至更广泛人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Celiac disease (CD) is a systemic autoimmune disorder triggered by gluten in genetically predisposed individuals. Accurate diagnosis remains challenging due to clinical heterogeneity and reliance on invasive biopsy. This study aimed to evaluate the diagnostic performance of a novel multiparametric membrane-based enzyme immunoassay (AESKUBLOTS®) for the simultaneous detection of IgA antibodies targeting eight CD-related antigens. METHODS: A retrospective, single-centre study was conducted on 180 participants: 80 with CD (30 untreated, 50 on gluten-free diet, GFD), 50 with non-celiac wheat sensitivity (NCWS), and 50 healthy controls (HC). Serum samples were analysed using the AESKU assay. Diagnostic accuracy was assessed via ROC curve analysis and 5-fold cross-validation, examining individual markers and a composite antibody score. RESULTS: The assay demonstrated high diagnostic performance, particularly in untreated CD patients. Anti-tTG neo IgA showed the highest accuracy (AUC=0.93), followed by anti-tTG IgA (AUC=0.92). A composite score of ≥4 positive markers yielded an AUC of 0.99, while ≥6 positive markers achieved 100 % specificity and PPV, with 76.7 % sensitivity. Notably, anti-mTG IgA levels were elevated in all CD patients regardless of diet, suggesting potential utility in monitoring or identifying ongoing mucosal immune activity. CONCLUSIONS: This multiparametric IgA assay offers a sensitive, specific, and non-invasive diagnostic tool for CD. Larger, prospective studies are warranted to confirm the clinical utility and expand the applicability to broader populations.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Gambino CM, Agnello L, Del Ben F, et al. Evaluating the performance of a multiparametric IgA assay for celiac disease diagnosis. Clin Chem Lab Med. 2025. PMID: 40831255. doi:10.1515/cclm-2025-0705

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。